In Egypt, we produce and commercialise medicines from our three manufacturing plants, which specialise in cephalosporins, general formulation, and oncology medicines. In addition, we commercialise the medicines of our pharmaceutical partners who rely on  our expertise and knowledge of the market.

Browse our products here - MENA products | Hikma

For 45 years, Hikma Pharmaceuticals has been making high-quality medicines and making them accessible to the people who need them.

We are a leading global pharmaceutical company with a strong presence in the Middle East and North Africa (MENA) region, Europe, Canada, and the United States. We manufacture and market a wide range of generic and branded products, including branded generics, injectables, and specialty pharmaceuticals.

We have 760 products, 32 manufacturing plants, 8 R&D centres and employ c8,800 employees worldwide*.

We have a strong focus on sustainability and focus on four areas where we can make a positive impact: advancing health and wellbeing; empowering our people; protecting the environment; and building trust through quality in everything we do.

*(Feb. 2023)

For all medical information queries and to report adverse events in Egypt, please contact  us by e-mail at: PVEgypt@hikma.com

Find out more about Global Medical Safety